124 related articles for article (PubMed ID: 21918031)
1. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
Ross JE; Scangarella-Oman NE; Miller LA; Sader HS; Jones RN
J Clin Microbiol; 2011 Nov; 49(11):3928-30. PubMed ID: 21918031
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322.
O'Dwyer K; Hackel M; Hightower S; Hoban D; Bouchillon S; Qin D; Aubart K; Zalacain M; Butler D
Antimicrob Agents Chemother; 2013 May; 57(5):2333-42. PubMed ID: 23478958
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
[TBL] [Abstract][Full Text] [Related]
4. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
Hackel MA; Karlowsky JA; Dressel D; Sahm DF
J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
[TBL] [Abstract][Full Text] [Related]
6. Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.
Ross JE; Sader HS; Ivezic-Schoenfeld Z; Paukner S; Jones RN
J Clin Microbiol; 2012 Oct; 50(10):3361-4. PubMed ID: 22814462
[TBL] [Abstract][Full Text] [Related]
7. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
Biedenbach DJ; Jones RN;
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
[TBL] [Abstract][Full Text] [Related]
8. Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone.
Ross JE; Liverman LC; Jones RN
J Clin Microbiol; 2011 Aug; 49(8):3009-11. PubMed ID: 21653768
[TBL] [Abstract][Full Text] [Related]
9. Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase.
Fritsche TR; Moet GJ; Jones RN
Clin Microbiol Infect; 2004 Sep; 10(9):857-60. PubMed ID: 15355422
[TBL] [Abstract][Full Text] [Related]
10. Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitor.
Anderegg TR; Biedenbach DJ; Jones RN;
Int J Antimicrob Agents; 2003 Jul; 22(1):84-6. PubMed ID: 12842335
[No Abstract] [Full Text] [Related]
11. Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.
Anderegg TR; Jones RN;
Diagn Microbiol Infect Dis; 2003 Jan; 45(1):73-6. PubMed ID: 12573554
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.
Lofland D; Difuntorum S; Waller A; Clements JM; Weaver MK; Karlowsky JA; Johnson K
J Antimicrob Chemother; 2004 Apr; 53(4):664-8. PubMed ID: 14973152
[TBL] [Abstract][Full Text] [Related]
13. Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor.
Anderegg TR; Jones RN;
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):55-7. PubMed ID: 14761722
[TBL] [Abstract][Full Text] [Related]
14. Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial.
Ross JE; Scangarella-Oman N; Jones RN
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):437-9. PubMed ID: 23461830
[TBL] [Abstract][Full Text] [Related]
15. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
[TBL] [Abstract][Full Text] [Related]
16. Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.
Miller AA; Traczewski MM; Huband MD; Bradford PA; Mueller JP
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315953
[TBL] [Abstract][Full Text] [Related]
17. Potent sub-MIC effect of GSK1322322 and other peptide deformylase inhibitors on in vitro growth of Staphylococcus aureus.
Butler D; Chen D; O'Dwyer K; Lewandowski T; Aubart K; Zalacain M
Antimicrob Agents Chemother; 2014; 58(1):290-6. PubMed ID: 24165188
[TBL] [Abstract][Full Text] [Related]
18. Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method.
Ross JE; Mendes RE; Jones RN
J Clin Microbiol; 2014 Sep; 52(9):3399-401. PubMed ID: 24920777
[TBL] [Abstract][Full Text] [Related]
19. Provisional quality control parameters and interpretive criteria for testing susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to quinupristin/dalfopristin (RP59500). Antimicrobial Testing Quality Control Group.
Fuchs P; Barry A; Brown S
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):197-201. PubMed ID: 9665303
[TBL] [Abstract][Full Text] [Related]
20. Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).
Jones RN; Biedenbach DJ;
Diagn Microbiol Infect Dis; 2001; 40(1-2):71-3. PubMed ID: 11448567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
